The app, which works on tablets and smartphones, allows vets to e-mail audit results directly to clients following an interactive calf health assessment at the farm.
MSD Animal Health’s youngstock marketing manager Robert Simpson said: “Our new app allows both parties to explore, record and score calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes.
“Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention.
"What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets”.
For more information about the app, contact your MSD account manager.
FirstVet says the funding will enable it to expand its service globally, including the United States, Germany, and France. It will also allow it to continue developing its product and introduce new features to improve the experience for pet owners and vets, such as new automation tools and integration with clinics' existing systems.
The latest round of financing takes FirstVet’s total funding to-date to €24.5M.
Founded in 2016 in Sweden, FirstVet currently has a presence in five markets: the United Kingdom, Norway, Denmark, Finland, and its native Sweden. The company says it has over 200,000 registered users and has provided consultations for over 150,000 pets since launch.
Currently, FirstVet consultations are offered free to millions of owners through partnerships with 20 insurance companies across all markets, including Bought By Many in the UK.
Co-founder David Prien said: "FirstVet is the first truly neutral stakeholder in the world to coordinate pet care. In what is a highly privatised industry, our reliable service provides value to the entire sector, and we are growing at an incredible rate."
Dechra Veterinary Products has announced that Intubeaze Oromucosal Spray is now back in stock.
Intubeaze is used for local anaesthesia of the laryngeal mucosa of cats to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.
The product had gone out of stock due to a temporary manufacturing problem which has now been fixed.
Intubeaze is a clear solution containing 2% w/v lidocaine hydrochloride, with 0.1% w/v chlorocresol as an antimicrobial preservative. Intubeaze is now available through all wholesalers.
For further information on Intubeaze please contact Dechra on 01743 441 632 or visit www.dechra.co.uk.
Petplan has announced the results of a survey which shows that with less than a week to go before microchipping becomes compulsory in England, Scotland and Wales, there is still confusion about the law amongst pet owners.
In the survey of 2,000 British dog owners, 25% had not heard of the new law and 40% didn't know that it also requires owners to keep their microchip details up to date.
40% of respondents said they'd be happy to pay over £500 as a reward if their dog went missing. Despite this, 40% of those who were aware of the new law but had yet to chip their dogs admitted they had not done so because of reservations about the cost of the procedure.
The survey also highlighted the fact that even the most careful of owners lose their dogs. Nearly 40% of losses reported in the survey happened when the owner was taking their pet on a daily walk and 47.1% of respondents reported having a dog escape from an apparently secure garden.
The survey also found that a third of lost dogs came to harm while missing, most of which (84.8%) needed veterinary care.
According to Petplan, despite more than half of dog owners citing expensive veterinary bills as one of their biggest concerns around dog ownership, over 45% of respondents reported not having their dogs insured.
Petplan has published information for pet owners about the new microchip law here: petplan.co.uk/microchip-dog-law-info.
IVC says this means its UK practices are on track to hit a group target of 5% by 2030, which follows in the footsteps of other IVC Evidensia territories such as Sweden and Norway, which have already reached figures of 4.9% and 5.9% respectively.
To achieve this progress, IVC says it has implemented a number of initiatives:
IVC says there has been a concerted efforts by its vets to become more aware of their own attitudes towards antibiotics and to educate their clients about the dangers of AMR.
One such example is Angharad Thomas, a veterinary surgeon from Fivelands Veterinary Centre in the West Midlands, who managed to reduce the amount of antibiotics prescribed in dentistry by 17.8% between 2022 and 2023:
She said: “Long dental treatments are a great time to chat to vet students, but one day, instead of quizzing them, I was trotting out my thoughts on the decision-making for the case when I reached post-operative drugs.
"Stopping here I asked: ‘What are you taught about this these days?’
"I suppose I wasn’t surprised to hear that antibiotics didn’t feature.
“It was a lightbulb moment: Why was I using post-operative antibiotics for my dental cases?
"I come from the generation of vets who were firmly taught never to give antibiotics to routine surgeries, so why was I continuing to use antibiotics in dentistry?
"All at once I felt terribly old and out-of-touch. I decided it was time for a change!”
“Given that reducing antibiotic usage is now fairly well recognised by the general public, owners have appeared very supportive.
"A day three post-operative check provides reassurance that their pet is healing and allows us an opportunity to intervene if required.”
“Being an ‘experienced’ vet can be a trade-off between textbook clinical decision-making and what we believe would work for our patients and their owners.
"Sometimes we need a paper or two to persuade us to change our ways, but here, going back to basic principles was enough for me.
“Twelve months later, after watching my cases for any mild complications and reflecting on the whether such complications could be attributed to the lack of antibiotics, I am convinced that this change has had no negative effects on my patients.”
https://ivcevidensia.co.uk/positive-pawprint
The Swadlincote and Melbourne-based IVC practice worked with a Great Workplaces by BVA accreditor during the pilot of the new scheme, to demonstrate its strengths against an accreditation framework covering four key themes: health and wellbeing, leadership and management, culture and learning and development.
In the report, the accreditor was particularly impressed by the practice’s strong leadership and management; its emphasis on accommodating flexibility for team members in various forms; a robust teamworking ethos; and a focus on continuous improvement.
British Veterinary Association President Elizabeth Mullineaux said: “We’re delighted to see Swadlincote Veterinary Centre become the first veterinary workplace to achieve Gold accreditation through Great Workplaces by BVA scheme.
"Congratulations to the whole practice team for this incredible recognition.
“Creating positive working environments and targeting areas for improvement are the key to tackling ongoing workforce challenges around recruitment and retention.
"We hope this first Gold accreditation inspires others to strive towards gaining recognition as workplaces where vet teams thrive.”
Ingrid Stevenson, Clinical Director at Swadlincote Veterinary Centre, said: “While we knew the practice was doing well, we didn’t go into this process expecting Gold at all.
"My practice manager and I were just both really keen to get some feedback and to find out what more we could do to help the team.
“We have several clinical accreditations in the practice, but it is the team that are responsible for achieving these and maintaining the high standards.
"I believe the team should be looked after, recognised and rewarded for their hard work and going above and beyond when necessary.
"The team were really pleased when I shared the news.
"It has certainly been good for team morale and a positive outcome to share with potential new recruits. '
“The accreditation process was a thorough assessment of the practice and our accreditor made us feel all at ease during the interviews.
"While we achieved Gold, which was unexpected, we have also learnt of areas to develop further over the coming months.
"Overall, it was a positive experience for our practice.”
www.bva.co.uk/take-action/good-veterinary-workplaces/
The Legislative Reform Order (LRO) to reconstitute the RCVS disciplinary committees separately from its Council has come into force and has amended the Veterinary Surgeons Act 1966 (VSA).
The LRO brings the RCVS in line with regulatory best practice and, says the College, improves the independence of its disciplinary processes, marking a major step towards the College becoming a 'First Rate Regulator'.
The amendment made by the LRO requires that the RCVS Preliminary Investigation and Disciplinary Committees are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently. This ensures that the same group of people is not responsible for setting the rules, investigating complaints and adjudication.
The LRO also brings lay people formally into the Preliminary Investigation Committee and will allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings.
The first external members will join the Disciplinary and Preliminary Investigation Committees from July 2013. After a two-year transition period, members of the RCVS Council will become ineligible for membership of these committees.
RCVS Registrar, Gordon Hockey, said: "The LRO has been the culmination of many years hard work by the RCVS and Defra, with the support of the British Veterinary Association. At first glance the change that the LRO makes to the Act may appear minor, but the reform fundamentally improves the way the veterinary profession is regulated, and will help to ensure public confidence in the RCVS disciplinary processes."
The programme, which was developed in collaboration with the NHS Leadership Academy, is designed to teach a number of skills that underpin good leadership, including decision-making, resilience, implementing an inclusive culture and encouraging reflective learning approaches. It comprises two free-to-access courses and an optional paid for assessment.
The College says that one of the programme's most popular aspects is its audio drama, which follows the lives of veterinary professionals living in the fictional county of Glenvern. The stories that depict the characters’ working lives seek to reveal the diverse leadership challenges that veterinary professionals face on a day-to-day basis. This in turn prompts the listener to reflect, consider how they would respond, and learn from their own experiences as well as those of other people.
The first course was piloted this summer, with over 550 veterinary surgeons, veterinary nurses, students and practice managers helping the College to develop and refine the material, whilst a group of learners are currently piloting the second course in the series.
Simon Patchett MRCVS, who works at Vets Now 24/7 Emergency and Specialty Hospital, Glasgow, said: "This course really highlighted leadership qualities that are often taken for granted. The course demonstrates that you do not need a status position in order to demonstrate effective leadership even though status positions are often where we look for leadership. I would recommend this course to both vets and nurses in clinical practice - it's a real eye opener, and as a result of doing the course perhaps we can see less age-restricted approach to leadership within the veterinary profession?"
Given the overwhelmingly positive feedback received on the first course the RCVS has now opened the programme to all veterinary professionals.
The programme is now accepting registrations for a new cohort of learners to begin the first of three courses on 26th November. A ‘sign-up’ email will be sent out to all veterinary surgeons and veterinary nurses ahead of the course starting.
Director of Leadership and Innovation at the RCVS, Anthony Roberts, said: "I am very pleased to be able to announce the launch of this programme. I would urge anyone with an interest in developing their leadership skills, as well as those looking to refine their longstanding leadership skills, to take part. The feedback we have received on the first course in this programme [please see Notes to Editors] has shown us that this MOOC has a far-reaching application, and is both educational and enjoyable. Whether you are a vet, veterinary nurse, practice manager or student, this programme will be relevant and useful in your professional career."
For more information, visit: www.rcvs.org.uk/leadershipmooc or email: leadership@rcvs.org.uk
The awards celebrate the achievements of remarkable people who dedicate their lives to improving animal health and welfare both in the UK and abroad. They are open to vets, vet nurses, farmers, animal welfare professionals and animal welfare teams who can be nominated to receive an award by fellow peers, friends and family or the general public.
There are nine nomination categories including a new one this year to recognise an international individual or team that stands out from the crowd by influencing and significantly contributing to making a visible difference in the world of animal welfare.
The categories are:
Chris Laurence Vet of the Year supported by Vet Record.
Vet Nurse of the Year supported by Agria Pet Insurance
Charity Team of the Year supported by PDSA
Charitable Contribution of the Year supported by Blue Cross
International Cat Care Welfare of the Year supported by International Cat Care
Farmer of the Year supported by R.A.B.I. and Farmers Guardian
Farm Educator of the Year supported by NADIS and Farmers Guardian
Outstanding Contribution to Animal Welfare supported by Your Dog and Your Cat magazines
Outstanding International Contribution to Animal Welfare supported by Ceva International
Nominations can be made at https://www.cevawelfare.com/click-here-to-nominate with nominations closing on Tuesday 31 December 2019.
Finalists will be announced at the beginning of February and winners will be revealed at an awards ceremony in Birmingham in April on the eve of BSAVA Congress.
Cuneyt Seckin, Managing Director of Ceva Animal Health UK and Ireland, said: "As an animal health company, animal welfare is a huge focus for us. The Ceva Animal Welfare Awards are an opportunity to formally recognise and congratulate outstanding animal welfare teams and individuals who contribute to the protection and welfare of animals in their daily lives."
For more information, visit www.cevawelfare.com.
Redonyl Ultra contains essential fatty acids, Palmitoylethanolamide (PEA) and Biotin.
PEA is a naturally-occurring bio modulator which Dechra says has scientifically proven activity against the mechanisms that contribute to inflammation and pain, while Biotin is important for synthesis of fatty acids and support of optimal skin condition.
Dechra Brand Manager Claire Morgan said: "Redonyl Ultra is a great addition to Dechra’s extensive Dermatology range that allows an holistic approach to treatment, control and maintenance of dermatological conditions.
"Allergic skin conditions are among the most common causes of skin and ear disease in cats and dogs, and it is estimated that up to 15 per cent of dogs are affected by atopy. In situations where an allergen cannot be avoided, multi-modal therapy is useful to control the clinical signs."
Redonyl Ultra comes in a convenient bottle size of 60 skittle capsules, in two strengths for different sized animals. The capsules can be opened and given with food or ingested directly, or swallowed whole for flexible administration.
For more information, visit http://bit.ly/2iNa2Ik
The most recent case of rabies in a bat in Great Britain was in July 2020 in Wimbourne, Dorset and there were four cases in 2019.
Like many wild animals, bats can carry a number of different pathogens, including European Bat Lyssaviruses (EBLVs) 1 and 2 – also referred to as bat rabies. The rabies virus is present in the saliva of infected bats and is usually spread to humans or other mammals by the bite of an infected bat. The virus may also enter the body via open wounds or mucous membranes.
The BSAVA says that whilst the risk of transmission to humans is considered low, those handling bats may be at an increased risk of contracting the disease and those who regularly handle bats should be vaccinated against rabies.
Those who are not vaccinated against the disease should assume that all bats are possible carriers of rabies. Individuals handling bats should wear gloves of a suitable thickness for the species of bat they are handling to avoid being bitten or scratched. Further information on how to safely contain and handle a bat can be found on the Bat Conservation Trust website.
In the event that an individual is bitten or scratched by a bat or exposed to bat saliva or nervous tissue in any other way, they should seek immediate medical advice. The contact area should be washed with soap and water, and any wounds must be disinfected. Further information can be found on the APHA, PHE and NHS websites.
In 2008, a case involving an injured bat carrying EBLV type 2 was treated by a vet and her staff, who were unaware of the potential of rabies risk from bats. The bat handlers had previously been vaccinated as recommended by the Department of Health but despite sustaining a needlestick injury during surgery, the vet and her staff had neither sought nor received post-exposure prophylaxis.1
Professor Ian Ramsey, president of the BSAVA, said: “Although this case was 12 years ago it is a pertinent reminder of why we need to be well-prepared when handling bats. Whilst the risk of human rabies infection from bats is low, the publication of the new statistics show that EBLVs are circulating in a small number of wild bats. Injured bats are often presented to small animal vets, so we have taken this opportunity to remind our members and others of the potential risks of rabies transmission, and how to mitigate against these.
"For more advice on the handling and treatment of wildlife casualties including bats, we advise vets to consult a reference book such as the BSAVA Manual of Wildlife Casualties."
Reference
Eurovet Animal Health has launched a new product, Bovocycline 2000 mg pessary for cattle.
Bovocycline 2000 is the only veterinary licenced antibiotic pessary for the treatment of retained foetal membranes in cattle. It is licenced for the treatment of post parturient disorders in cattle, for administration after dystocia, retained foetal membranes (RFMs) and endometritis.
According to Eurovet, the incidence of retained foetal membranes in cows varies from zero to 25 per cent, but the average is around 4 per cent in most herds. RFMs result in reduced cow fertility and a higher risk of culling due to poor fertility. Pessaries are still considered the preferred treatment for vulval discharges in cattle by farmers.
Ruth Vernon, Technical Services Manager for Eurovet said: "The control of post partum problems in cattle is rarely straight forward, but it is great to have a veterinary licensed treatment designed specifically for this purpose, in one pessary that contains 2000mgs tetracycline".
For more information please contact Eurovet Animal Health. Tel: 01223 257933. E-mail: office@eurovet-ah.co.uk www.eurovet-ah.co.uk
In his talk, 'Digital Veterinary Practice', Adam presents an exciting and compelling vision as to how technology will transform the profession and enable veterinary surgeons to offer better care to more patients.
His talk begins with an interesting look at how technological change has gathered pace in recent years, before considering some of the emerging technologies that could be applied to veterinary practice.
In particular, he talked about the so-called 'Internet of things': the way more and more 'things' other than computers are connected to the Internet.
There are now about 9bn 'things' connected to the internet, by 2020 there are expected to be 50bn. Adam predicted that more and more of them are going to be worn by animals: to measure reproductive health in farm animals; to track performance in equines; and to monitor behaviour and activity in companion animals.
Adam discussed how there is already a smart litter box which measures an animal’s habits, an oral pill camera that can take 360 degree internal photos, 3D printed drugs and digitised microscopy. By uniting these technologies with increasingly accurate virtual reality technology, he said, long-distance examinations could become a real possibility.
In relation to the role of the RCVS, Adam explored how the profession could be proactive in engaging with these technologies, such as by: using regulation as a mechanism to attract 'disruptors' to work alongside the profession; identifying areas of retraining and creating targeted learning opportunities; fostering an entrepreneurial mindset; creating an early-adopter network of practices to foster initial collaboration; and framing industry challenges as targeted problems whose solutions can be crowd-sourced.
Davies Veterinary Specialists (DVS), the Hertfordshire-based private small animal referral practice, has launched a pro bono scheme to help deliver the practice's multi-specialist care to deserving patients and clients.
All first opinion practices are eligible to apply for the scheme, which will allow an average of one patient per month to receive free treatment.
Clive Elwood, managing director of DVS said: "The DVS board was unanimous in its desire to introduce a pro bono scheme to help the needy, specifically those patients that are likely to achieve a full recovery following specialist care, but are otherwise precluded from referral because of their owners' particular circumstances."
Pro bono requests are open to all practices. They will be based on advocacy from the clinical head of the referring practice and on genuine need.
To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood on 01582 883950.
Boehringer Ingelheim Vetmedica has extended its Metacam 0.5 mg/ml Oral Suspension for Cats range with the launch of a 30ml bottle size, which the company says will last the average 5 kg cat for two months.
According to Boehringer, the new 30ml bottle will offer owners a cost saving compared to purchasing two 15 ml bottles. In addition, it will provide greater prescription options for veterinary practices currently stocking 3ml and 15 ml bottles,,
Andrew Francis, Metacam brand manager said: "The new 30ml bottle of Metacam Oral Suspension for Cats will provide both veterinary practices and their clients with a product that is great for the long-term treatment of chronic pain in cats in one convenient pack."
For further information on Metacam, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
The rationale for completing a course of antibiotics has always been to prevent the growth of drug-resistant bacteria. However, the article says there is little evidence to support this idea, and that in fact, taking antibiotics for longer than necessary presents a greater risk of causing antibiotic resistance.
Responding to article, BVA Junior Vice President John Fishwick said: "We're very aware of the global threat antimicrobial resistance poses to human and animal health, and the UK veterinary profession is committed to the responsible use of antibiotics. Medicines should never be used to compensate for poor husbandry practices and routine habitual prophylactic use in healthy animals to prevent disease is a no-go.
"The article in the BMJ suggests that antibiotics should be used for as short a period as possible, and that we should move away from the concept of following a predetermined course. This may indeed be a very important advance, but it is far too early to determine how this would work in veterinary practice. We need to clearly establish the evidence supporting it.
"We support the researchers’ calls for clinical trials to determine the most effective strategies for antibiotic treatment. Until further studies are conducted, it is too early to change the way we prescribe medicines and vets should continue to prescribe as previously, only when necessary. It is also vital that clients continue to follow the directions given by their vets, both in terms of dosage and duration of treatment, carefully."
The course counts for four hours CPD, split into six short sessions which can be completed in your own time.
Presented by Dr Dan Cripwell BSc (Hons) BVSc CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox, the sessions consist of:
There is a quiz at the end of each module, following which, you can download a CPD certificate.
Suzy Ramsay, head of sales and marketing at Jurox (UK) Limited, said: “We are committed to developing unique and world class anaesthesia and analgesic products and practices within the animal health industry through the provision of up-to-date technical support and education. Our new Jurox Anaesthesia Academy CPD platform will enable veterinary professionals to adopt an evidence-based approach to their anaesthetic product choice and, in turn, help achieve the best possible anaesthetic outcomes for their patients.”
For access to the Jurox Anaesthesia Academy CPD platform, visit https://cpd.jurox.co.uk.
For further information, contact your local Jurox account manager, phone 0800 500 3171 or email customerservice@jurox.co.uk.
The programme for the day includes a talk by Matt Rendle, an exotics veterinary nurse, about wound healing in reptiles and the work of the Veterinary Wound Library.
There are also talks about current veterinary practice concerning Chelonia (with a focus on egg retention), the Asian turtle crisis, zoo conservation work, reptile rescue work and perceptions of Chelonia in captivity.
Tickets cost £30-£50, and include refreshments, lunch and optional Sunday workshops.
For more details or to reserve your place, email: turtlesurvivaleurope@gmail.com, or visit: https://www.turtlesurvival.eu/
Boehringer Ingelheim Vetmedica has launched Prascend, the first licensed product for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses, commonly known as Equine Cushing's Disease.
Prascend contains pergolide mesylate, and is supplied in 60 and 160 tablet packs of 1mg tablets.
Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "Many horses and ponies with Cushing's Disease benefit from treatment with pergolide, however, with less than 200 people still being treated with pergolide in the UK, many vets and horse owners have expressed concern that they will not be able access treatment in the future.
"We have invested in dedicated veterinary manufacturing of this product, and can assure our customers that the future supply of Prascend is guaranteed irrespective of any changes of in the human generic market."
For further information, visit www.prascend.co.uk or call 01344 746959
The company says the series will help practices set-up, post content and measure the effectiveness of their social media channels.
There are three introductory videos titled: ‘What are the benefits and why is social media key to my practice?’, ‘Measurement, maintenance and management’ and ‘Planning’.
The first video covers a back-to-basics introduction to social media channels, including Facebook and Instagram. The second video explains how to measure the success of social channels and how to manage posts and content. The final video covers the importance of planning and the use of content calendars to highlight events and awareness days, as well as helpful tools and features such as Facebook Live.
The four how-to guides explain:
The social media videos and how-to guides are part of PetNatter, Boehringer Ingelheim’s free veterinary resource, designed to help veterinary practices stay in touch with owners and help them care for their pets. Originally launched in mid-July, PetNatter provides veterinary practices with professionally crafted social media, newsletter and website content.
Grace Tonner, territory manager at Boehringer Ingelheim said: “Social media plays a big part in our social lives and it is an increasingly important channel in business communities too, which has the potential to help practices maintain and develop vital relationships with pet owners.
"While most vet practices recognise that social media should play an important role in starting and maintaining communications with clients and potential clients, particularly during challenging times such as the COVID-19 pandemic, finding the time, resource and skills to be effective with social media can be challenging.
"Our brilliant series of short, easy-to-understand social media videos and how-to guides provides veterinary professionals with the essential knowledge, tools and confidence to make vet practice social media a hit. Using the videos and guides will enable vet practices to get their social media up and running in just 15 minutes.”
For further information on the social media videos and how-to guides contact your local Boehringer Ingelheim territory manager or visit petnatter.co.uk/how-to.
Vetswest, the veterinary support services company, has been acquired by MWI Veterinary Supply, a subsidiary of the US multinational, AmerisourceBergen.
MWI already owns Centaur and VetSpace, and the agreement will allow it to further expand the range of services it offers the animal health profession in the UK.
Jim Cleary, Executive Vice President of AmerisourceBergen and President of MWI Veterinary Supply said: “This partnership reflects our commitment to the success of veterinary practices across the globe. We’re proud to welcome Vetswest to the MWI family as we continue to expand our services in our mission to be the best resource to the animal health profession.”
Vetswest offers group business support services for its 235 member veterinary practices including negotiating manufacturer terms and a proprietary IT system that supports pricing intelligence, inventory information and reporting on purchasing activity. The company also provides access to ancillary services for veterinary surgeons to help manage human resources, continuing professional development, insurance offerings, pension services and other areas which support the growth of member practices.
Vetswest's retiring managing director David Buckley said: “The resources of MWI and AmerisourceBergen will allow us to bring new innovation to the market and additional benefits to Vetswest members. I’m excited about Vetswest’s future under the leadership of Chris Sobey and as part of the MWI and AmerisourceBergen family.”
Chris Sobey, who will become the new managing director of Vetswest following his tenure as Vetswest’s business development director said: “Our goal has always been to improve efficiencies and services for our members through scale and with our new relationship with MWI and AmerisourceBergen, we will be well positioned to further this core mission of our organisation.’’
The equine events will initially take place at Rossdales Equine Hospital in Suffolk on 22nd October and at Ashbrook Veterinary Hospital in Cheshire on 5th December.
The roadshow will see a range of speakers renowned in the fields of equine veterinary medicine and QI share practical examples of improving outcomes for equine patients. Interactive workshops, real-life scenarios and case studies will show how QI techniques can be applied in practice to help teams prevent and respond to errors.
Confirmed speakers include Professor Debra Archer, Head of Equine Surgery and Professor in Equine Surgery at the University of Liverpool, Dr Alice Bird, Senior Clinical Anaesthetist at the Animal Health Trust and Dr Rachel Dean, Director of Clinical Research and Excellence in Practice, VetPartners.
President Elect of BEVA, Tim Mair, said: "There are many challenges to being an equine vet and running a successful equine practice. Even in large practices and equine hospitals, there is a risk that we operate in our own little bubble and assume that what we are doing is best practice, whereas in reality we could often do a better job.
"Clinical governance and quality improvement are tools that allow us to critically appraise our day-to-day work and identify ways in which we can continuously improve what we do – to the benefit of our patients and clients, as well as to ourselves."
The canine hip dysplasia roadshow will begin on 9th October in Gatwick, Surrey.
The event will review the condition prevalent in dogs, how best to investigate it and the available treatment options. Case examples will be used to show how the evidence can be evaluated, explain how to measure treatment outcomes and show how the use of checklists can help minimise potential errors.
It will be hosted by Mark Morton, RCVS Specialist in Small Animal Surgery (Orthopaedics). He said: "As vets we probably all undertake bits of QI on a day-to-day basis (whether we realise it or not!) but there is so much more we can do to embed it into our clinical work. Checklists, treatment guidelines and clinical auditing significantly improve our patient care and our outcomes.
"Whilst looking at hip dysplasia and the treatment options in detail, hopefully this roadshow will show how we can apply these ideas to improve our management of this condition as well as using them elsewhere.”
For the full programme of each event and to buy tickets, visit bit.ly/RCVSKnowledgeEvents.
Anyone interested in booking an RCVS Knowledge roadshow for their region can do so by contacting ebvm@rcvsknowledge.org.
Samantha, who was a recipient of the Malaysian Prime Minister’s Scholarship, has a degree in genetics, molecular biology and microbiology, and a PhD in cancer research from University College London.
She was diagnosed with ADHD at the age of 40, which led her to set up ADHD Girls, an organisation that helps people with ADHD access employment and works with businesses to help them understand ADHD.
Samantha's talk is part of a module on neurodiversity, which will open with an exploration of neurodiversity and the challenges of diagnosis, before looking at how you can better support those in practice teams, as well as neurodivergent clients and students.
The session will wrap up with a discussion about how to cultivate greater inclusivity and understanding around those who are neurodivergent within the veterinary professions.
Being neurodivergent means that your brain works differently from the average person, meaning there may be differences in social preference, ways of communicating, ways of learning and ways of perceiving the environment.
Samantha said: “No two brains are the same. But what if you were born with a brain that constantly makes you feel like everything you do differentiates you from everyone else?”
“My talk introduces neurodiversity in the context of society, casting light on ADHD and autism, and how this impacts the workplace and one’s quality of life, and what we can do to build a compassionate culture, starting with the conversations we have at work.
"I’m really excited to talk at the BSAVA Congress and meet other professionals in the veterinary field.”
After her lecture, she will be partaking in a panel discussion around the challenges of diagnosis of neurodivergence alongside Laura Playforth, a vet who has been diagnosed with both bipolar and autism and is currently Group Quality Improvement Director at IVC Evidensia.
Andy Green, Vice Chair of the BSAVA Congress Programme Committee chair said: “We are delighted to have Samantha delivering our keynote this year on such an important topic.
"Neurodiversity is becoming an increasingly important area of focus and understanding across society and we have a significant population of neurodivergent people working as vets, nurses and in other roles, many of whom may not as yet have a diagnosis.”
“We also need to recognise that many pet owners and clients are neurodivergent.
"Samantha is ideally placed to shine a spotlight on this subject, using her own story and life experience to deliver a greater understanding of what it actually means to be neurodivergent and how businesses/practices can understand, embrace and support neurodivergent members of the work force and community.”
Early bird tickets for BSAVA Congress 2023 are currently on sale with 3-day and 1-day tickets available to purchase. Get your ticket now: https://www.bsavaevents.com/bsavacongress2023/en/page/home.
Norbrook has announced the re-launch of its range of intramammary tubes for lactating and dry cows, to promote holistic herd health and responsible use of antimicrobials.
The company’s range, which includes products across a number of antibiotic classes, primarily targets clinical cases of mastitis in lactating cows, and removal or prevention of infection around the dry period.
Chris Geddes MRCVS, Marketing Manager at Norbrook, says the re-launch is focused on modernising the range and making it clearer for practice staff and farmers to avoid confusion between lactating cow and dry cow products: “We have a wide range of 11 products containing a variety of antimicrobials: for example Duofast is the only lactating cow product to contain trimethoprim and sulfadiazine. We are working with vets to promote responsible use by farmers, for example through the use of our teat sealant Noroseal for Selective Dry Cow Therapy."
The full range includes Duofast, Lactaclox, Cefimam LC, Combiclav, Noroclav and Multiject for the lactating cow; Cefimam DC, Noroclox, Bovaclox and Bovaclox DC Xtra for the dry cow; and teat sealant Noroseal.
Norbrook has also produced a best practice guide to mastitis control, available for vets in English and Polish, which can be shared with farmers.
Chris added: "We recognise the need to reduce overall use of antimicrobials, especially for disease prevention – as well as using non-antimicrobial products such as teat sealants. These practices, together with the recent focus on using older classes of antimicrobials, mean that as an industry we need to adopt a holistic and targeted approach to herd health management.
"We believe that by providing additional information to aid with prevention of disease, and re-launching our intramammary range to make it clearer when products should be used, we can help to achieve that."
Norbrook says the full range of products is in stock, but some wholesalers may hold components of the old range as the new range is phased in.
Ceva Animal Health is launching Fiprospot, a new spot-on for dogs and cats.
Fiprospot contains fipronil, with its proven efficacy against fleas in dogs and cats and against ticks in dogs. The product is packaged in a novel dosing pipette which can be placed on its stand before gathering the dog or cat for their treatment. There are five pack sizes available for Fiprospot: one for cats and four for dogs, with either three or six pipettes per pack.
To find out more about Fiprospot and other products in Ceva's antiparasite range, telephone the customer support team on (01494) 781510 or contact your local Ceva territory manager.